Our team of expert reporters is making its way to Chicago for the American Diabetes Association annual scientific sessions. We’ve got a lot in store for you.
The President's Oral Sessions promise to be highlights of the meeting. The first session, on Friday, will emphasize provocative basic science trials, but one presentation stands out for us: The investigators evaluated whether islet transplantation can restore glucose counterregulation in patients with long-standing type 1 diabetes. Watch upcoming newsletters for our report on the findings from that research.
Tuesday's President's Oral Session will focus on clinical research, with some data that may have an immediate affect on how you practice:
• Should your type 1 diabetes patients count carbs? A meta-analysis sorts through the evidence.
• Should you go straight to triple therapy in a newly diagnosed type 2 diabetes patient? One team of investigators studied just that.
• What more can you learn about diabetes treatment and cancer risk from the ORIGIN trial?
With nearly 2,000 abstracts being presented, we can’t stop there. Look for our live and continuing reports from oral abstract and poster sessions, symposia, and "hot topic" Current Issues sessions.
If you're attending, get the mobile app, wear red on Sunday to Stop Diabetes, sign up for the 5K@ADA fun run, and check out our recommendations on making the most of Chicago while you’re there.